Acetylcysteine and carbocysteine for acute respiratory tract infections in paediatric patients without chronic bronchopulmonary disease

  • Protocol
  • Intervention

Authors

  • M Chalumeau,

  • YCM Duijvestijn,

  • J Smucny,

  • G Pons,

  • G Breart


Dr Martin Chalumeau, INSERM U149, 123 boulevard de Port-Royal, Paris, 75014, FRANCE. martin.chalumeau@wanadoo.fr.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1. To assess the efficacy of the use of acetylcysteine and carbocysteine as symptomatic treatment for acute respiratory tract infections in paediatric patients without chronic bronchopulmonary disease.

2. To evaluate the safety of the use of acetylcysteine and carbocysteine as symptomatic treatment for acute respiratory tract infections in paediatric patients without chronic bronchopulmonary disease.

3. To establish the benefit-risk ratio of the use of acetylcysteine and carbocysteine as symptomatic treatment for acute respiratory tract infections in paediatric patients without chronic bronchopulmonary disease.